GO:0005227 calcium-activated cation channel activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005227 describes a molecular function: a transmembrane channel that conducts inorganic cations only after calcium binds to the channel complex or one of its subunits.
• The term covers both non-selective cation channels such as TRPM4 and calcium-activated chloride channels with cation permeability such as TMEM16F.
• Calcium-activated cation channels are central to cardiac electrical activity, immune cell function, and sensory transduction.
• TRPM4 is the best structurally characterized member, with cryo-EM structures revealing calcium-binding sites and a tetrameric architecture.
• Dysregulation of these channels is linked to cardiac arrhythmias, cancer necrosis pathways, and anoctamin-related disorders.
• CRISPR knockout, point-mutation, and knock-in models are essential to dissect the contribution of individual channel domains to calcium sensitivity and ion selectivity.
Description
Calcium-activated cation channel activity (GO:0005227) is a molecular function that enables the transmembrane transfer of inorganic cations through a channel that opens only when calcium binds to the channel complex or one of its constituent parts. This functional class includes non-selective cation channels such as TRPM4 and calcium-activated chloride channels that also conduct cations, such as TMEM16F. Unlike voltage-gated or ligand-gated channels that respond to membrane potential or neurotransmitters, these channels directly couple intracellular calcium signals to cation flux, making them critical effectors of calcium signaling in excitable and non-excitable cells. Researchers study this term because it bridges calcium signaling, membrane excitability, and ion homeostasis, with direct implications for cardiac arrhythmias, immune responses, and sensory transduction. The functional diversity of these channels arises from distinct protein families, including TRP channels, anoctamins, and polycystins, each with unique calcium-binding sites and regulatory mechanisms. Understanding GO:0005227 at the molecular level is therefore essential for targeting these channels in disease and for interpreting functional genomics data.
calcium-activated cation channel activity At A Glance
| GO ID | GO:0005227 |
|---|---|
| GO term | calcium-activated cation channel activity |
| Ontology | molecular_function |
| Synonym | calcium activated cation channel activity; intracellular calcium-activated potassium channel; polycystin |
| Major function | Enables calcium-dependent transmembrane transfer of inorganic cations |
| Gating stimulus | Binding of calcium to the channel complex or a constituent part |
| Permeant ions | Inorganic cations, often non-selective (e.g., Na+, K+, Ca2+) |
| Representative proteins | TRPM4, TMEM16F, polycystins, and other calcium-activated cation channels |
| Related diseases | Cardiac arrhythmias, cancer, anoctaminopathies, sensory disorders |
What Is GO:0005227?
GO:0005227, calcium-activated cation channel activity, is defined as the ability to enable the transmembrane transfer of an inorganic cation through a channel that opens when a calcium cation has been bound by the channel complex or one of its constituent parts. In other words, the channel itself or an associated subunit senses intracellular calcium, and this binding event triggers a conformational change that allows cations such as sodium, potassium, or calcium to flow across the membrane. This activity is distinct from calcium-activated chloride channel activity because the permeant ions are cations, and it is distinct from voltage-gated cation channels because the primary gating stimulus is calcium binding rather than membrane potential.
Why Is calcium-activated cation channel activity Important in Cell Biology?
Calcium-activated cation channel activity is important because it provides a direct molecular link between intracellular calcium signals and membrane electrical behavior, thereby shaping action potentials, cell volume, and immune cell activation. In the heart, these channels contribute to afterdepolarizations and arrhythmogenesis, making them potential antiarrhythmic targets. In cancer, TRPM4-mediated cation flux has been shown to mediate immunogenic therapy-induced necrosis, highlighting a role in cell death pathways. In sensory systems, calcium-activated nonselective cation channels are involved in olfactory transduction, as demonstrated in insect olfactory receptor neurons. Furthermore, the interaction between TRP channels and anoctamins reveals broader regulatory networks that influence calcium signaling and ion transport. Consequently, understanding GO:0005227 is essential for both basic physiology and therapeutic development.
• Cardiac arrhythmias: calcium-activated nonselective cation channels contribute to afterdepolarizations and triggered activity in cardiomyocytes.
• Cancer: TRPM4 mediates immunogenic therapy-induced necrosis, linking cation flux to cell death.
• Sensory transduction: calcium-activated nonspecific cation channels are involved in olfactory signaling in insects.
• Epithelial transport: calcium-activated and nucleotide-sensitive nonselective cation channels regulate ion and water transport in kidney collecting duct cells.
• Channelopathies: mutations in TMEM16F alter anion and cation permeability, causing blood disorders and skeletal defects.
• Protein interaction networks: TRP channels and anoctamins functionally interact, expanding the regulatory landscape of calcium-activated cation transport.
• Evolutionary conservation: calcium-activated cation channels are found from protists to mammals, indicating fundamental roles in cell physiology.
• Drug discovery: these channels are emerging targets for modulating excitability, secretion, and cell death.
• Structural biology: cryo-EM structures of TRPM4 provide a template for understanding calcium gating and ion permeation.
• Functional genomics: GO:0005227 enables annotation of gene function in knockout and mutation studies.
What Happens During calcium-activated cation channel activity?
Calcium binding and channel activation
In simple terms: Calcium ions bind to the channel, causing it to open.
The channel complex contains calcium-binding sites, often located in the cytosolic domains. When intracellular calcium rises, calcium binds to these sites, inducing conformational changes that open the channel pore. For TRPM4, structural studies have revealed a calcium-binding site in the cytoplasmic domain that is essential for activation. Similarly, TMEM16F is activated by calcium and conducts both anions and cations, with distinct permeability properties.
Cation permeation and selectivity
In simple terms: Once open, the channel allows cations to flow across the membrane.
Calcium-activated cation channels are typically non-selective, permitting the passage of Na+, K+, and sometimes Ca2+. The pore architecture determines the relative permeability of different cations. For example, TRPM4 is a non-selective cation channel that is impermeable to calcium but conducts monovalent cations. In contrast, TMEM16F exhibits both anion and cation permeability, with the cation permeability contributing to its physiological roles.
Regulation by calcium and other signals
In simple terms: The channel's activity is tuned by calcium levels and other cellular signals.
Channel activity is tightly regulated by intracellular calcium concentration, which can be influenced by IP3 receptors, ryanodine receptors, and calcium influx pathways. In cardiomyocytes, calcium-activated nonselective cation channels are activated during calcium overload and contribute to arrhythmogenesis. Additionally, nucleotide sensitivity has been reported for some channels, such as the calcium-activated and nucleotide-sensitive nonselective cation channel in M-1 mouse cortical collecting duct cells.
Physiological roles in excitable and non-excitable cells
In simple terms: These channels help cells respond to calcium signals in many tissues.
In excitable cells, they modulate membrane potential and excitability; in non-excitable cells, they regulate ion transport, cell volume, and secretion. For instance, in olfactory receptor neurons of the silkmoth, a calcium-activated nonspecific cation channel is involved in sensory transduction. In Paramecium, a calcium-activated large conductance non-selective cation channel contributes to behavioral responses.
Key Genes Involved in GO:0005227 calcium-activated cation channel activity
The following genes encode proteins that exhibit calcium-activated cation channel activity or are closely associated with this function, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRPM4 | Calcium-activated non-selective cation channel; conducts monovalent cations | Structural basis of calcium gating; role in cardiac arrhythmias and cancer necrosis |
| TMEM16F (ANO6) | Calcium-activated channel with anion and cation permeability | Phospholipid scrambling; blood coagulation; skeletal development |
| ANO1 (TMEM16A) | Calcium-activated chloride channel; may also conduct cations under certain conditions | Interacts with TRP channels; smooth muscle contraction; cancer |
| PKD1 (Polycystin-1) | Forms calcium-activated cation channel complex with PKD2 | Polycystic kidney disease; mechanosensation [synonym: polycystin] |
| PKD2 (Polycystin-2, TRPP2) | Calcium-activated cation channel; permeable to Ca2+ | Polycystic kidney disease; calcium signaling |
| TRPM5 | Calcium-activated non-selective cation channel | Taste transduction; thermosensation |
| TRPA1 | Calcium-activated cation channel; interacts with anoctamins | Pain, inflammation, sensory transduction |
| TRPV4 | Calcium-activated cation channel; interacts with anoctamins | Osmosensation, mechanotransduction |
| KCNMA1 (BK channel) | Calcium-activated potassium channel; synonym 'intracellular calcium-activated potassium channel' | Neuronal excitability; smooth muscle tone |
| KCNMB1 | Regulatory subunit of BK channel | Modulates calcium sensitivity and pharmacology |
| KCNN4 (SK4) | Calcium-activated potassium channel | Immune cell activation; volume regulation |
| CLCA1 | Calcium-activated chloride channel; may have cation permeability | Mucus production; airway disease |
| BEST1 | Calcium-activated chloride channel; possible cation conductance | Retinal degeneration; bestrophinopathies |
| CATSPER1 | Calcium-activated cation channel in sperm | Male fertility; sperm motility |
| CATSPER2 | Calcium-activated cation channel in sperm | Male fertility; sperm hyperactivation |
| PIEZO1 | Mechanosensitive cation channel; may be modulated by calcium | Touch, proprioception, red blood cell volume |
| PIEZO2 | Mechanosensitive cation channel; calcium-dependent modulation | Touch, proprioception, baroreception |
| TMEM63A | Calcium-activated cation channel; osmosensitive | Myelination; brain development |
How Is calcium-activated cation channel activity Regulated?
The activity of calcium-activated cation channels is regulated at multiple levels. Intracellular calcium concentration is the primary regulator, with calcium binding to cytosolic domains or auxiliary subunits triggering channel opening. Calcium sensitivity can be modulated by phosphorylation, nucleotides, and interacting proteins. For example, the M-1 mouse cortical collecting duct channel is nucleotide-sensitive, indicating that ATP or other nucleotides can influence gating. In cardiomyocytes, calcium-activated nonselective cation channels are regulated by calcium released from intracellular stores and by membrane stretch. Additionally, TRP channels and anoctamins functionally interact, suggesting that heteromeric complexes or regulatory cross-talk can modulate channel activity. These regulatory mechanisms ensure that cation flux is tightly coupled to cellular calcium signals.
calcium-activated cation channel activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRPM4 | Cardiac arrhythmias; immunogenic therapy-induced necrosis | Knockout mice; cardiomyocyte-specific KO; cancer cell lines with point mutations |
| TMEM16F | Scott syndrome; blood coagulation defects | Knockout mice; patient-derived cells; knock-in of patient mutations |
| PKD1/PKD2 | Polycystic kidney disease | Knockout mice; kidney organoids; knock-in of disease mutations |
| ANO1 | Cancer; smooth muscle disorders | Knockout mice; overexpression in cancer cell lines; point mutations |
| KCNMA1 | Epilepsy; movement disorders | Knockout mice; knock-in of gain-of-function mutations |
Cardiac arrhythmias
Calcium-activated nonselective cation channels in cardiomyocytes contribute to afterdepolarizations and triggered activity, which are hallmarks of arrhythmias. Under conditions of calcium overload, these channels open and allow cation influx, depolarizing the membrane and promoting abnormal automaticity. Targeting these channels may offer therapeutic benefits for arrhythmia management.
Cancer and cell death
TRPM4, a calcium-activated non-selective cation channel, mediates immunogenic therapy-induced necrosis in cancer cells. This suggests that cation flux through TRPM4 is a critical step in a form of regulated necrosis that can be exploited for cancer therapy. Modulating TRPM4 activity could enhance the efficacy of immunogenic therapies.
Anoctaminopathies and blood disorders
TMEM16F (ANO6) is a calcium-activated channel with both anion and cation permeability, and mutations in TMEM16F cause Scott syndrome, a bleeding disorder characterized by defective phospholipid scrambling. The cation permeability of TMEM16F may contribute to its physiological functions, and understanding its ion selectivity is important for developing treatments.
Sensory and neurological disorders
Calcium-activated cation channels are involved in sensory transduction, as shown in olfactory receptor neurons. Dysfunction of these channels could lead to sensory deficits. Additionally, interactions between TRP channels and anoctamins may be relevant to neurological disorders, although further research is needed.
From calcium-activated cation channel activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TRPM4 affect cardiac arrhythmia susceptibility? | TRPM4 knockout mouse; cardiomyocyte-specific KO |
| How does a specific calcium-binding site mutation alter TRPM4 gating? | Point-mutation knock-in of TRPM4 calcium-binding residue |
| Can TMEM16F cation permeability be separated from anion permeability? | Knock-in of point mutations in TMEM16F pore; patch-clamp |
| What is the role of TRPM4 in immunogenic therapy-induced necrosis? | TRPM4 knockout cancer cell lines; overexpression of TRPM4 |
| Does ANO1 interact with TRP channels in vivo? | Double knockout or tagged knock-in of ANO1 and TRPA1 |
| Is calcium-activated cation channel activity required for olfactory transduction? | Knockout of the channel in insect olfactory neurons; electrophysiology |
How to Study the calcium-activated cation channel activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion channel currents, calcium sensitivity, selectivity | Functional characterization of wild-type and mutant channels |
| Calcium imaging | Intracellular calcium concentration dynamics | Monitoring activation of calcium-activated channels in live cells |
| Cryo-EM | Three-dimensional structure of channel complexes | Understanding calcium-binding sites and pore architecture |
| Site-directed mutagenesis | Effect of specific amino acid changes on channel function | Mapping functional domains |
| RNA-seq | Gene expression profiles | Identifying channel expression in tissues or disease models |
| Proteomics | Protein interactions and post-translational modifications | Discovering regulatory partners of calcium-activated channels |
| CRISPR knockout | Loss-of-function phenotype | Determining the contribution of a specific channel to cellular processes |
| CRISPR knock-in | Precise mutation or tag introduction | Studying disease-associated mutations or tagging endogenous proteins |
Patch-clamp electrophysiology
Patch-clamp recording is the gold standard for measuring calcium-activated cation channel activity. It allows direct measurement of single-channel currents, calcium sensitivity, and ion selectivity. For example, inside-out patches with varying calcium concentrations can determine the EC50 for calcium activation. This method is essential for validating channel function in knockout or mutant cells.
Calcium imaging and fluorescence assays
Calcium imaging using fluorescent indicators such as Fura-2 or GCaMP can monitor intracellular calcium changes that activate these channels. Combined with electrophysiology, it provides a comprehensive view of channel activation in live cells. In cardiomyocytes, calcium imaging reveals spontaneous calcium release events that trigger cation channel opening.
Structural biology (cryo-EM and X-ray crystallography)
Cryo-EM structures of TRPM4 have revealed the architecture of a calcium-activated cation channel, including calcium-binding sites and the pore region. These structures provide a framework for understanding how calcium binding leads to channel opening and for designing mutations to test functional hypotheses.
Molecular biology and mutagenesis
Site-directed mutagenesis combined with heterologous expression is used to dissect the roles of specific residues in calcium binding, ion permeation, and regulation. For instance, mutating calcium-coordinating residues in TRPM4 abolishes activation. Similarly, mutations in TMEM16F alter ion permeability.
How CRISPR Can Be Used to Study GO:0005227 calcium-activated cation channel activity
Knockout
CRISPR knockout is used to eliminate the expression of a calcium-activated cation channel gene, such as TRPM4 or TMEM16F, to study its physiological roles. For example, TRPM4 knockout cancer cells have been used to demonstrate its requirement for immunogenic therapy-induced necrosis. Knockout models help establish causality between channel activity and cellular phenotypes.
Point Mutation
Point mutations can be introduced via CRISPR to alter specific amino acids involved in calcium binding or ion permeation. This approach is valuable for dissecting the molecular determinants of channel gating and selectivity. For instance, mutating the calcium-binding site in TRPM4 abolishes activation, as shown by structural and functional studies. Similarly, point mutations in TMEM16F can alter its ion permeability.
Knock-in
Knock-in of disease-associated mutations or tags allows researchers to study channel function in a physiological context. For example, knocking in a patient mutation in TMEM16F can model Scott syndrome and reveal how the mutation affects cation permeability. Tagged knock-in (e.g., GFP or HA) enables visualization and immunoprecipitation of endogenous channels.
Overexpression
Overexpression of calcium-activated cation channels in heterologous systems, such as HEK293 cells, is widely used for electrophysiological and structural studies. For example, TRPM4 was overexpressed and purified for cryo-EM structure determination. Overexpression can also be used to study gain-of-function effects in disease models.
How EDITGENE Supports calcium-activated cation channel activity Research
Researchers studying calcium-activated cation channel activity-related genes often need to determine whether a candidate gene is causally involved in a specific physiological or pathological process. This requires precise genetic manipulation, such as knockout, point mutation, knock-in, or overexpression, followed by functional assays. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such studies.
Contact EDITGENE today to design your custom CRISPR model for calcium-activated cation channel activity research.
Frequently Asked Questions About calcium-activated cation channel activity
What is calcium-activated cation channel activity?
Calcium-activated cation channel activity (GO:0005227) is a molecular function that enables the transmembrane transfer of inorganic cations through a channel that opens when calcium binds to the channel complex or one of its constituent parts.
What genes are involved in calcium-activated cation channel activity?
Genes include TRPM4, TMEM16F (ANO6), ANO1, PKD1, PKD2, TRPM5, KCNMA1, and others that encode calcium-activated cation channels.
What is the role of TRPM4 in calcium-activated cation channel activity?
TRPM4 is a calcium-activated non-selective cation channel that conducts monovalent cations and is involved in cardiac arrhythmias and immunogenic therapy-induced necrosis.
How is calcium-activated cation channel activity measured?
It is measured using patch-clamp electrophysiology, calcium imaging, and structural biology techniques such as cryo-EM.
What diseases are associated with calcium-activated cation channel activity?
Diseases include cardiac arrhythmias, Scott syndrome, polycystic kidney disease, and certain cancers.
What is the difference between calcium-activated cation and chloride channels?
Calcium-activated cation channels conduct cations such as Na+ and K+, while calcium-activated chloride channels conduct Cl-. Some channels, like TMEM16F, can conduct both.
Can CRISPR be used to study calcium-activated cation channels?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study the function of these channels.
What is the structure of a calcium-activated cation channel?
Structures such as TRPM4 reveal a tetrameric architecture with calcium-binding sites in the cytoplasmic domain and a central pore for cation conduction.
What are the synonyms for GO:0005227?
Synonyms include calcium activated cation channel activity, intracellular calcium-activated potassium channel, and polycystin.
Why is calcium-activated cation channel activity important for drug discovery?
These channels are potential therapeutic targets for arrhythmias, cancer, and blood disorders, and understanding their structure and regulation aids drug design.
Conclusion
Calcium-activated cation channel activity (GO:0005227) is a fundamental molecular function that couples intracellular calcium signals to cation flux across membranes. It is mediated by diverse proteins such as TRPM4, TMEM16F, and polycystins, and plays critical roles in cardiac function, sensory transduction, immune responses, and cell death. Dysregulation of these channels is linked to arrhythmias, cancer, and genetic disorders, making them important therapeutic targets. Advances in structural biology and CRISPR-based models continue to illuminate the mechanisms of calcium gating and ion permeation, offering new opportunities for drug discovery and precision medicine.
References
- 1. Stabilini S et al.. 2021. Anion and Cation Permeability of the Mouse TMEM16F Calcium-Activated Channel.. Int J Mol Sci 22(16) PMID: 34445284
- 2. Guo J et al.. 2017. Structures of the calcium-activated, non-selective cation channel TRPM4.. Nature 552(7684):205-209 PMID: 29211714
- 3. Guinamard R et al.. 2006. Calcium-activated nonselective cation channels in mammalian cardiomyocytes.. Trends Cardiovasc Med 16(7):245-50 PMID: 16980182
- 4. Saitow F et al.. 1997. A calcium-activated, large conductance and non-selective cation channel in Paramecium cell.. Biochim Biophys Acta 1327(1):52-60 PMID: 9247166
- 5. Zufall F et al.. 1991. A calcium-activated nonspecific cation channel from olfactory receptor neurones of the silkmoth Antheraea polyphemus.. J Exp Biol 161:455-68 PMID: 22141156
- 6. Korbmacher C et al.. 1995. A calcium-activated and nucleotide-sensitive nonselective cation channel in M-1 mouse cortical collecting duct cells.. J Membr Biol 146(1):29-45 PMID: 7563035
- 7. Ghosh S et al.. 2023. Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy-Induced Necrosis.. Cancer Res 83(18):3115-3130 PMID: 37522838
- 8. Takayama Y et al.. 2024. Interaction between TRP channels and anoctamins.. Cell Calcium 121:102912 PMID: 38823351
